Published in Eur J Clin Pharmacol on December 18, 1978
Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide. Br J Clin Pharmacol (1987) 0.78
Effect of guanfacine on vigilance. Br J Clin Pharmacol (1980) 0.75
Are blood pressure surges associated with sympathetic stimulation aggravated by beta-adrenoceptor antagonist treatment? Postgrad Med J (1986) 0.75
Haemorrhagic fever with renal syndrome, 1993: endemic or unrecognised pandemic? Lancet (1993) 3.77
A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings. J Clin Endocrinol Metab (1995) 2.01
Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin Nephrol (1998) 1.54
Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes. Nephron (1990) 1.38
[Cardiovascular risk factors in diabetic nephropathy]. Med Klin (Munich) (1997) 1.38
Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28
Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem (1997) 1.21
Ototoxic side-effects of high doses of frusemide in patients with uraemia. Postgrad Med J (1971) 1.12
Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function. J Lab Clin Med (1992) 1.08
[Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency]. Dtsch Med Wochenschr (1969) 1.03
Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr (2000) 0.97
[Guanfacinum (BS 100-14) in long-term therapy of severe hypertension]. Verh Dtsch Ges Inn Med (1978) 0.96
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant (1995) 0.95
Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells. J Am Soc Nephrol (1996) 0.92
[Acute, reversible hearing damages due to rapid high-dosage furosemide infusions in terminal renal insufficiency]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1970) 0.92
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. Kidney Int (2007) 0.91
Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int (1998) 0.91
Hormonal changes in brain death and immune activation in the donor. Transpl Int (2000) 0.90
N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis (2001) 0.88
Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr (2000) 0.88
Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure. Kidney Int Suppl (2001) 0.87
[Beta2-microblogulin in serums: a measure of glomerular filtration]. Dtsch Med Wochenschr (1974) 0.87
Mono- and divalent electrolyte patterns, pCO 2 and pH in relation to flow rate in normal human parotid saliva. Eur J Clin Invest (1972) 0.87
Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int (1986) 0.86
Calcium antagonists in the treatment of hypertension. Contrib Nephrol (1982) 0.86
Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Organs (1995) 0.86
Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett (1997) 0.86
Advanced glycation end products in end-stage renal disease and their removal. Nephron (2001) 0.86
Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. Cell Mol Biol (Noisy-le-grand) (1998) 0.85
Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. Am J Nephrol (1988) 0.85
Mechanisms and clinical significance of cell volume regulation. Nephrol Dial Transplant (1998) 0.85
Studies on natriuretic properties of methylguanidine. Res Exp Med (Berl) (1972) 0.85
Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch Intern Med (1996) 0.85
Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Transplant Proc (1996) 0.83
Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr (2001) 0.83
Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int Suppl (1983) 0.82
Chronic ethanol ingestion enhances catabolism and muscle protease activity in acutely uremic rats. Nephron (1988) 0.82
Role of proteases in hypercatabolic patients with renal failure. Kidney Int Suppl (1983) 0.82
Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies. Nephrol Dial Transplant (1990) 0.82
Biochemical assessment and clinical evaluation of a bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice. Int J Artif Organs (1992) 0.82
Uremic pneumonitis. Evidence for participation of proteolytic enzymes. Contrib Nephrol (1984) 0.82
Effect of cellular hydration on protein metabolism. Miner Electrolyte Metab (1997) 0.82
Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant (1996) 0.82
Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension. Am J Nephrol (1998) 0.82
Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring. Toxicol Lett (2005) 0.82
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res (2010) 0.82
Circulatory changes during mental stress in tetraplegic and paraplegic man. Klin Wochenschr (1982) 0.82
Role of alcohol in clinical nephrology. Klin Wochenschr (1985) 0.82
Low-molecular-weight protein-permeable cuprammonium rayon haemofilter. Nephrol Dial Transplant (1992) 0.82
Autonomic neuropathy in chronic renal insufficiency. Comparative analysis of diabetic and nondiabetic patients. Nephron (1985) 0.82
Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis (2001) 0.81
Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis (1999) 0.81
Neutrophil activation in acute renal failure and sepsis. Arch Surg (1990) 0.81
Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron (1986) 0.81
[Acute kidney failure caused by Hantaviruses]. Ther Umsch (1994) 0.81
Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: potential role of lysosomal proteinases. Am J Nephrol (1995) 0.81
Homocysteine exerts genotoxic and antioxidative effects in vitro. Toxicol In Vitro (2007) 0.81
The aging rat kidney displays low glomerular and tubular proteinase activities. Am J Kidney Dis (1994) 0.81
[Increased cAMP concentration in parotid secretion in arterial hypertension: relationship to plasma-renin activity (author's transl)]. Dtsch Med Wochenschr (1975) 0.81
Abnormalities of carbohydrate metabolism in spontaneously hypertensive rats. Klin Wochenschr (1988) 0.81
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Clin Nephrol (2000) 0.81
Glandular adenylate cyclase system in genetic hypertension: age-dependent response to catecholamines. Eur J Pharmacol (1988) 0.81
Improvement of dialyzer compatibility by reduction of membrane surface area. Clin Nephrol (1986) 0.81
Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. Kidney Blood Press Res (1999) 0.80
DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan. Kidney Int Suppl (2001) 0.80
[Studies on uremic sympathicopathy in vitro and in vivo]. Dtsch Med Wochenschr (1973) 0.80
Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells. Am J Physiol (1995) 0.80
Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats. Drugs Exp Clin Res (2001) 0.80
Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the rat. Clin Exp Hypertens (1995) 0.80
Lactic acidosis. Clin Nephrol (1977) 0.80
Oxidative stress and non-enzymatic glycation in IgA nephropathy. Clin Nephrol (2005) 0.80
Release of granulocyte proteinases during hemodialysis. Am J Nephrol (1983) 0.79
[Hantavirus infection with acute kidney failure]. Dtsch Med Wochenschr (1992) 0.79
[Incidence and spectrum of malignant disease among dialysis patients in North Bavaria]. Dtsch Med Wochenschr (2002) 0.79
Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol (1989) 0.79
[The effect of mainly alpha-adrenergic drugs, indirect sympathomimetrics and dopamine on exocrine pancreatic function. Studies in the isolated cat pancreas (author's transl)]. Res Exp Med (Berl) (1978) 0.79
Salivary kallikrein excretion in hypertension. Klin Wochenschr (1979) 0.79
[Nephrotic syndrome of the adult. 1]. Dtsch Med Wochenschr (1971) 0.79
Relation between different treatment modalities and genomic damage of end-stage renal failure patients. Kidney Blood Press Res (2006) 0.79
Long-term effects of essential amino acids supplementation in patients on regular dialysis treatment. Clin Nephrol (1975) 0.79
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. J Hum Hypertens (2003) 0.79
Dose-dependent stimulation/inhibition effects of cyclosporin A on lysosomal cathepsin activities in cultured proximal tubule cells. Res Exp Med (Berl) (1995) 0.79
Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. Life Sci (1996) 0.79
The role of magnesium and substances promoting the transport of electrolytes. Acta Cardiol (1973) 0.79
[Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms]. Schweiz Med Wochenschr (1997) 0.79
Role of L-arginine-derived NO in ischemic acute renal failure in the rat. Ren Fail (1994) 0.79
[Flow rate-dependent excretion of electrolytes in human parotid and submandibular saliva after stimulation with pilocarpine and lemon juice]. Laryngol Rhinol Otol (Stuttg) (1982) 0.79